4D Molecular Therapeutics IncNASDAQ:FDMT
- LAST PRICE7.8700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots7.6000/ 2
- Ask / Lots8.5000/ 1
- Open / Previous Close--- / 7.8700
- Day Range---
- 52 Week Range
- Volume3
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FDMT |
|---|---|---|
| 09:32 ET | 3590 | 7.51 |
| 09:33 ET | 580 | 7.625 |
| 09:35 ET | 2825 | 7.56 |
| 09:37 ET | 1149 | 7.5 |
| 09:39 ET | 1300 | 7.5473 |
| 09:42 ET | 300 | 7.48 |
| 09:44 ET | 10995 | 7.59 |
| 09:46 ET | 5932 | 7.52 |
| 09:48 ET | 5286 | 7.555 |
| 09:50 ET | 300 | 7.5 |
| 09:51 ET | 2700 | 7.5 |
| 09:53 ET | 798 | 7.46 |
| 09:55 ET | 862 | 7.5 |
| 09:57 ET | 490 | 7.5073 |
| 10:00 ET | 200 | 7.465 |
| 10:02 ET | 300 | 7.44 |
| 10:04 ET | 426 | 7.5 |
| 10:06 ET | 3100 | 7.49 |
| 10:08 ET | 3905 | 7.49 |
| 10:09 ET | 2596 | 7.515 |
| 10:11 ET | 537 | 7.495 |
| 10:13 ET | 721 | 7.485 |
| 10:15 ET | 1100 | 7.47 |
| 10:18 ET | 499 | 7.4973 |
| 10:20 ET | 156 | 7.5 |
| 10:22 ET | 900 | 7.505 |
| 10:24 ET | 300 | 7.5 |
| 10:26 ET | 500 | 7.485 |
| 10:27 ET | 300 | 7.46 |
| 10:29 ET | 300 | 7.5 |
| 10:31 ET | 300 | 7.5 |
| 10:33 ET | 200 | 7.505 |
| 10:36 ET | 330 | 7.51 |
| 10:38 ET | 732 | 7.53 |
| 10:40 ET | 1250 | 7.5 |
| 10:42 ET | 200 | 7.5 |
| 10:44 ET | 863 | 7.55 |
| 10:45 ET | 1500 | 7.54 |
| 10:47 ET | 500 | 7.54 |
| 10:49 ET | 100 | 7.54 |
| 10:51 ET | 2405 | 7.58 |
| 10:54 ET | 500 | 7.56 |
| 10:56 ET | 4400 | 7.575 |
| 10:58 ET | 208 | 7.545 |
| 11:00 ET | 200 | 7.55 |
| 11:02 ET | 600 | 7.55 |
| 11:03 ET | 453 | 7.58 |
| 11:05 ET | 200 | 7.56 |
| 11:07 ET | 1800 | 7.59 |
| 11:09 ET | 588 | 7.609 |
| 11:12 ET | 806 | 7.59 |
| 11:14 ET | 585 | 7.56 |
| 11:16 ET | 4298 | 7.55 |
| 11:18 ET | 1557 | 7.59 |
| 11:20 ET | 1327 | 7.58 |
| 11:21 ET | 100 | 7.57 |
| 11:23 ET | 300 | 7.555 |
| 11:25 ET | 329 | 7.57 |
| 11:27 ET | 5925 | 7.635 |
| 11:30 ET | 500 | 7.61 |
| 11:34 ET | 1300 | 7.61 |
| 11:36 ET | 1632 | 7.6 |
| 11:38 ET | 400 | 7.6 |
| 11:39 ET | 500 | 7.6 |
| 11:41 ET | 475 | 7.6073 |
| 11:43 ET | 2295 | 7.63 |
| 11:45 ET | 2391 | 7.6 |
| 11:48 ET | 200 | 7.6 |
| 11:50 ET | 100 | 7.59 |
| 11:52 ET | 2952 | 7.64 |
| 11:54 ET | 500 | 7.63 |
| 11:56 ET | 1272 | 7.61 |
| 11:57 ET | 3987 | 7.61 |
| 11:59 ET | 60062 | 7.625 |
| 12:01 ET | 11323 | 7.645 |
| 12:03 ET | 2547 | 7.63 |
| 12:06 ET | 1315 | 7.64 |
| 12:08 ET | 300 | 7.63 |
| 12:10 ET | 2102 | 7.63 |
| 12:12 ET | 849 | 7.63 |
| 12:14 ET | 1300 | 7.61 |
| 12:15 ET | 8451 | 7.66 |
| 12:17 ET | 2700 | 7.655 |
| 12:19 ET | 2800 | 7.7 |
| 12:21 ET | 1003 | 7.72 |
| 12:24 ET | 3622 | 7.69 |
| 12:26 ET | 200 | 7.67 |
| 12:28 ET | 1890 | 7.665 |
| 12:30 ET | 300 | 7.65 |
| 12:32 ET | 2399 | 7.65 |
| 12:33 ET | 3471 | 7.62 |
| 12:35 ET | 3600 | 7.61 |
| 12:37 ET | 400 | 7.61 |
| 12:39 ET | 1298 | 7.62 |
| 12:42 ET | 6366 | 7.555 |
| 12:44 ET | 1700 | 7.535 |
| 12:46 ET | 300 | 7.535 |
| 12:48 ET | 5966 | 7.56 |
| 12:50 ET | 142 | 7.565 |
| 12:51 ET | 7261 | 7.565 |
| 12:53 ET | 675 | 7.56 |
| 12:55 ET | 500 | 7.56 |
| 12:57 ET | 1500 | 7.56 |
| 01:00 ET | 900 | 7.56 |
| 01:02 ET | 700 | 7.54 |
| 01:04 ET | 402 | 7.56 |
| 01:06 ET | 5770 | 7.555 |
| 01:08 ET | 1793 | 7.555 |
| 01:09 ET | 400 | 7.55 |
| 01:11 ET | 700 | 7.55 |
| 01:13 ET | 200 | 7.55 |
| 01:15 ET | 2130 | 7.55 |
| 01:18 ET | 4157 | 7.57 |
| 01:20 ET | 810 | 7.56 |
| 01:22 ET | 5593 | 7.55 |
| 01:24 ET | 800 | 7.54 |
| 01:26 ET | 2280 | 7.53 |
| 01:27 ET | 300 | 7.55 |
| 01:29 ET | 3020 | 7.55 |
| 01:31 ET | 944 | 7.5776 |
| 01:33 ET | 1449 | 7.6 |
| 01:36 ET | 1359 | 7.62 |
| 01:38 ET | 1846 | 7.63 |
| 01:40 ET | 1500 | 7.63 |
| 01:42 ET | 1300 | 7.62 |
| 01:44 ET | 3997 | 7.63 |
| 01:45 ET | 400 | 7.61 |
| 01:47 ET | 4607 | 7.62 |
| 01:49 ET | 100 | 7.62 |
| 01:51 ET | 3194 | 7.64 |
| 01:54 ET | 1125 | 7.63 |
| 01:56 ET | 5236 | 7.633 |
| 01:58 ET | 2000 | 7.62 |
| 02:00 ET | 500 | 7.63 |
| 02:02 ET | 900 | 7.64 |
| 02:03 ET | 1500 | 7.64 |
| 02:05 ET | 4965 | 7.66 |
| 02:07 ET | 1138 | 7.65 |
| 02:09 ET | 2384 | 7.65 |
| 02:12 ET | 3606 | 7.65 |
| 02:14 ET | 2915 | 7.7 |
| 02:16 ET | 1100 | 7.7 |
| 02:18 ET | 2800 | 7.67 |
| 02:20 ET | 8859 | 7.73 |
| 02:21 ET | 3048 | 7.75 |
| 02:23 ET | 4922 | 7.81 |
| 02:25 ET | 3957 | 7.85 |
| 02:27 ET | 5494 | 7.8 |
| 02:30 ET | 100 | 7.815 |
| 02:32 ET | 2295 | 7.85 |
| 02:34 ET | 2691 | 7.83 |
| 02:36 ET | 5557 | 7.86 |
| 02:38 ET | 700 | 7.84 |
| 02:39 ET | 730 | 7.833 |
| 02:41 ET | 3063 | 7.84 |
| 02:43 ET | 864 | 7.85 |
| 02:48 ET | 1000 | 7.84 |
| 02:50 ET | 100 | 7.83 |
| 02:52 ET | 500 | 7.83 |
| 02:54 ET | 3232 | 7.835 |
| 02:56 ET | 800 | 7.825 |
| 02:57 ET | 3814 | 7.815 |
| 02:59 ET | 2900 | 7.815 |
| 03:01 ET | 800 | 7.81 |
| 03:03 ET | 2100 | 7.78 |
| 03:06 ET | 200 | 7.77 |
| 03:08 ET | 5321 | 7.77 |
| 03:10 ET | 2018 | 7.79 |
| 03:14 ET | 1630 | 7.78 |
| 03:15 ET | 1500 | 7.805 |
| 03:19 ET | 2339 | 7.79 |
| 03:21 ET | 3752 | 7.795 |
| 03:24 ET | 100 | 7.795 |
| 03:26 ET | 900 | 7.8 |
| 03:28 ET | 1400 | 7.8 |
| 03:30 ET | 3500 | 7.78 |
| 03:32 ET | 6924 | 7.725 |
| 03:33 ET | 1676 | 7.75 |
| 03:35 ET | 830 | 7.74 |
| 03:37 ET | 5161 | 7.74 |
| 03:39 ET | 5761 | 7.78 |
| 03:42 ET | 213 | 7.78 |
| 03:44 ET | 1112 | 7.79 |
| 03:46 ET | 4236 | 7.801 |
| 03:48 ET | 2269 | 7.8 |
| 03:50 ET | 8246 | 7.8 |
| 03:51 ET | 6035 | 7.83 |
| 03:53 ET | 5722 | 7.8792 |
| 03:55 ET | 11026 | 7.84 |
| 03:57 ET | 14711 | 7.88 |
| 04:00 ET | 84691 | 7.87 |
Nov 21, 2024
DJ 4D Molecular Therapeutics Initiated at Underweight by Morgan Stanley, from 6:34AM ET on Thursday Nov 21, 2024 by Dow Jones
6:34AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 14, 2024
DJ 4D Molecular Therapeutics Is Maintained at Buy by Chardan Capital, from 4:54PM ET on Thursday Nov 14, 2024 by Dow Jones
4:54PM ET on Thursday Nov 14, 2024 by Dow JonesDJ 4D Molecular Therapeutics Price Target Maintained With a $36.00/Share by HC Wainwright & Co., from 1:41PM ET on Thursday Nov 14, 2024 by Dow Jones
1:41PM ET on Thursday Nov 14, 2024 by Dow JonesDJ 4D Molecular Therapeutics Is Maintained at Outperform by RBC Capital, from 12:04PM ET on Thursday Nov 14, 2024 by Dow Jones
12:04PM ET on Thursday Nov 14, 2024 by Dow Jones4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
4D Molecular Therapeutics Inc | 346.7M | -2.8x | --- |
AC Immune SA | 332.4M | -7.3x | --- |
C4 Therapeutics Inc | 295.8M | -2.7x | --- |
TScan Therapeutics Inc | 269.5M | -4.5x | --- |
Uniqure NV | 294.9M | -1.2x | --- |
Iteos Therapeutics Inc | 312.0M | -2.7x | --- |
Company Information
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease (both in modulator ineligible and eligible populations), 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, it has two product candidates in preclinical development: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency lung disease.
Contact Information
- Headquarters
- 5858 Horton Street #455, EmeryvilleEMERYVILLE, CA, United States 94608
- Phone
- 510-505-2680
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- John Milligan
- President, Chief Operating Officer
- Fariborz Kamal
- Chief Executive Officer, Co-Founder, Director
- David Kirn
- Chief Financial and Business Officer
- Uneek Mehra
- Chief Medical Officer
- Robert Kim
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $346.7M |
|---|---|
Revenue (TTM) | $18.0K |
Shares Outstanding | 46.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.75 |
EPS | $-2.76 |
Book Value | $7.15 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 19,261.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -935,416.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
